class action lawsuit glp 1 Ozempic for Blindness, Stomach Paralysis and Injury Claims Ozempic/GLP-1 Drug Class Action Case
Description
Introduction: Migraine is a prevalent neurological disorder characterized by recurrent headaches with autonomic and neurological symptoms, significantly impacting quality of life globally
The yerba mate market is set to grow from US$2.1 Bn in 2026 to US$3.0 Bn by 2033, driven by rising demand and a steady 5.2% CAGR
Eat less, move more is not a long-term weight management solution
Many people on GLP-1 medications hit a weight loss plateau
Pfizer signed a licensing deal worth up to $495 million with Sciwind Biosciences for type 2 diabetes drug ecnoglutide in China
